Abstract:Introduction: Corin is a protease in the natriuretic peptide system. Deleterious CORIN variants are associated with hypertension and heart disease. It remains unclear if and to what extent corin deficiency may contribute to heart failure (HF). Methods: Corin knockout (KO) mice were used as a model. Cardiac function was assessed by echocardiography and tissue analysis in Corin KO mice at different ages or subjected to transverse aortic constriction (TAC), which increased pressure overload. Heart and lung tissues were analyzed for cardiac hypertrophy and lung edema using wheat germ agglutinin, Sirius red, Masson's trichrome, and Prussian blue staining. Recombinant corin was tested for its effect on cardiac function in the TAC-operated Corin KO mice. Selected gene expression in the heart was examined by RT-PCR. ELISA was used to analyze factors in plasma. Results: Corin KO mice had progressive cardiac dysfunction with cardiac hypertrophy and fibrosis after 9 months of age, likely due to chronic hypertension. When Corin KO mice were subjected to TAC at 10–12 weeks of age, cardiac function decreased more rapidly than in similarly treated wild-type mice. When the TAC-operated Corin KO mice were treated with recombinant corin protein, cardiac dysfunction, hypertrophy, and fibrosis were ameliorated. The corin treatment also decreased the gene expression associated with cardiac hypertrophy and fibrosis, increased plasma cGMP levels, lowered plasma levels of N-terminal pro-atrial natriuretic peptide, angiotensin II, and aldosterone, and lessened lung edema in the Corin KO mice subjected to TAC. Conclusion: Corin deficiency impairs cardiac function and exacerbates HF development in mice. Corin protein may be used to reduce cardiac hypertrophy and fibrosis, suppress the renin-angiotensin-aldosterone system, and improve cardiac function in HF.

Golgi α-mannosidases regulate cell surface N-glycan type and ectodomain shedding of the transmembrane protease corin

Distinct Roles of N-Glycosylation at Different Sites of Corin in Cell Membrane Targeting and Ectodomain Shedding

Ectodomain Shedding And Autocleavage Of The Cardiac Membrane Protease Corin

Role of Glycosylation in Corin Zymogen Activation

Human Corin Isoforms with Different Cytoplasmic Tails That Alter Cell Surface Targeting

A common CORIN variant in hypertension reduces corin intracellular trafficking by exposing an inhibitory N-terminus

A Novel Cytoplasmic Tail Motif Regulates Mouse Corin Expression on the Cell Surface.

Functional Analysis of the Transmembrane Domain and Activation Cleavage of Human Corin

Identification of Domain Structures in the Propeptide of Corin Essential for the Processing of Proatrial Natriuretic Peptide

N-glycosylation in the Protease Domain of Trypsin-Like Serine Proteases Mediates Calnexin-Assisted Protein Folding

Function and Regulation of Corin in Physiology and Disease.

Functional Analysis of Corin Protein Domains Required for PCSK6-mediated Activation

Abstract 18126: Ectodomain Shedding and Autocleavage of the Cardiac Membrane Protease Corin

The role of actomyosin in the regulation of syndecan-1 in hyperosmosis

Corin Variant Associated With Hypertension And Cardiac Hypertrophy Exhibits Impaired Zymogen Activation And Natriuretic Peptide Processing Activity

Protease corin expression and activity in failing hearts.

Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes

Corin: new insights into the natriuretic peptide system.

Corin Mutation R539C from Hypertensive Patients Impairs Zymogen Activation and Generates an Inactive Alternative Ectodomain Fragment

A Corin Variant Identified in Hypertensive Patients That Alters Cytoplasmic Tail and Reduces Cell Surface Expression and Activity.

Corin deficiency impairs cardiac function in mouse models of heart failure